• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.67% Nasdaq Down2.47%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    1.72 Down 0.09(4.98%) 2:10PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 9,847   7,751   9,138   9,181  
    Cost of Revenue3,616  3,248  3,219  3,115  
    Gross Profit 6,231   4,503   5,919   6,066  
    Operating Expenses
    Research Development18,502  20,170  22,072  24,201  
    Selling General and Administrative6,924  9,655  9,028  8,844  
    Non Recurring -  3,972   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (19,195) (29,294) (25,181) (26,979)
    Income from Continuing Operations
    Total Other Income/Expenses Net(674)530  446  1,926  
    Earnings Before Interest And Taxes(19,869)(28,764)(24,735)(25,053)
    Interest Expense1,679  1,695  1,683  1,754  
    Income Before Tax(21,548)(30,459)(26,418)(26,807)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,548)(30,459)(26,418)(26,807)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,548) (30,459) (26,418) (26,807)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,548) (30,459) (26,418) (26,807)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.